Mark Donohue | Vice President, Investor Relations and Corporate Communications |
Rob Stewart | President and Chief Executive Officer |
Bryan Reasons | Chief Financial Officer |
Joe Todisco | Senior Vice President of Specialty Commercial |
Randall Stanicky | RBC Capital Markets |
Louise Chen | Cantor Fitzgerald |
Elliot Wilbur | Raymond James |
David Amsellem | Piper Jaffray |
David Risinger | Morgan Stanley |
Chris Schott | J. P. Morgan |
Dana Flanders | Goldman Sachs |
Gary Nachman | BMO Capital Markets |
Ami Fadia | Leerink Partners |
Dewey Steadman | Canaccord Genuity |
David Buck | B.Riley FBR |
Tim Chiang | BTIG |
Good day. My name is Jay, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Amneal Pharmaceuticals Third Quarter 2018 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session.